rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1993-2-19
|
pubmed:abstractText |
In an ongoing effort to develop novel nonnucleoside, specific human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) inhibitors, a series of 3-[(pyridylmethyl)amino]- and 3-[(phenylmethyl)amino]-2-pyridinone derivatives was synthesized and tested for HIV-1 RT inhibitory activity. The more potent compounds have a 2'-methoxy group and 4'- and/or 5'-aliphatic substituents on the pyridyl and phenyl rings. Several of the more potent compounds were also evaluated for antiviral activity in MT-4 cell culture. From this series of compounds, 3-[N-[(5-ethyl-2-methoxy-6-methyl-3-pyridyl)methyl]amino]-5-ethyl-6- methylpyridin-2(1H)-one (6) was selected for clinical evaluation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-2623
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
249-55
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7678654-Aminopyridines,
pubmed-meshheading:7678654-Animals,
pubmed-meshheading:7678654-Antiviral Agents,
pubmed-meshheading:7678654-Cells, Cultured,
pubmed-meshheading:7678654-HIV Reverse Transcriptase,
pubmed-meshheading:7678654-Haplorhini,
pubmed-meshheading:7678654-Pyridones,
pubmed-meshheading:7678654-Rats,
pubmed-meshheading:7678654-Reverse Transcriptase Inhibitors,
pubmed-meshheading:7678654-Structure-Activity Relationship
|
pubmed:year |
1993
|
pubmed:articleTitle |
Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-one.
|
pubmed:affiliation |
Merck Research Laboratories, West Point, Pennsylvania 19486.
|
pubmed:publicationType |
Journal Article
|